• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Despite improvements in cardiovascular implantable electronic device (CIED) design,
application of timely infection control practices, and administration of antibiotic prophylaxis at …

Pacemakers, implantable cardiac defibrillators, and cardiac resynchronization therapy
devices are potentially life-saving treatments for a number of cardiac conditions, but are not …

Perceptions of lead reliability, performance, complications and approaches to management
have evolved dramatically since the inception of pacemaker and implantable defibrillator …

Objectives: We describe the management and outcome of permanent pacemaker (PPM) and
implantable cardioverter-defibrillator (ICD) infections in a large cohort of patients seen at a …

Infections related to implantable cardiac electronic devices (ICEDs), including pacemakers,
implantable cardiac defibrillators and cardiac resynchronization therapy devices, are …

Background The incidence of cardiac device infection is not well understood. Bloodstream
infection (BSI) in patients with permanent pacemakers or implantable cardioverter …

Background. Several host-and procedure-related factors have been reported to increase the
risk of permanent pacemaker (PPM) infection on the basis of descriptive analyses of case …

OBJECTIVE To describe management of patients with permanent pacemaker (PPM)-and
implantable cardioverter-defibrillator (ICD)-related endocarditis. PATIENTS AND METHODS …

Background: Infective endocarditis caused by non-HACEK (species other than Haemophilus
species, Actinobacillus actinomycetemcomitans, Cardiobacterium hominis, Eikenella …